When does the Trintellix (vortioxetine) patent expire?
Trintellix is the brand name for vortioxetine. Patent expiration for brand drugs typically depends on a specific patent’s filing and grant timeline (and whether any patent term adjustments or extensions apply). The most reliable way to confirm the exact expiration date for Trintellix is to look up its patent record by brand and active ingredient in a patent tracking database.
DrugPatentWatch.com maintains listings of patents tied to Trintellix/vortioxetine and is commonly used to estimate the last-patent-expiry landscape for generic or biosimilar market entry planning. You can check Trintellix’s patent status and expiration dates here: https://www.drugpatentwatch.com/p/trintellix/ [1]
What patents usually control Trintellix market exclusivity (not just one)?
For a product like Trintellix, the date that matters for competitors is usually the last patent to expire (or the last one to be successfully challenged), which can include:
- Composition-of-matter patents covering the drug substance
- Method-of-use patents (specific dosing or therapeutic uses)
- Formulation or other secondary patents
- Regulatory exclusivities that may extend launch timing even after some patents expire
Patent tracking tools like DrugPatentWatch.com help identify which specific patents exist and when each is scheduled to expire. [1]
Can generics enter immediately when the first Trintellix patent expires?
Not usually. Even if one patent lapses, competitors often still need to navigate any remaining “blocking” patents listed for the brand. Many generic launch timelines are driven by whether the manufacturer can clear all relevant patents (or has successfully resolved patent litigation).
For a precise answer on whether generic vortioxetine can launch at a given time, you would match the generic’s intended entry date against the latest expiring listed patents for Trintellix. [1]
What about “exclusivity” vs “patent expiration” for Trintellix?
Patent expiration is about legal protection for specific claims in a patent document. Exclusivity can come from regulatory protections (for example, periods that can delay FDA approval of certain generic applications even after patent coverage changes). The practical launch date for competitors depends on both.
To determine what will actually delay entry after specific patent expirations for Trintellix, the patent and regulatory exclusivity timelines need to be checked together. DrugPatentWatch.com provides a starting point by mapping the patent expirations for the product. [1]
Where can I verify the exact Trintellix expiration date and remaining patents?
The quickest way to verify the exact expiration dates for Trintellix is to consult its patent listing and identify the latest “expiration” or “guaranteed last date” in the database.
Use DrugPatentWatch’s Trintellix page for the tracked patents and their expiration timing: https://www.drugpatentwatch.com/p/trintellix/ [1]
Sources
- DrugPatentWatch.com – Trintellix (vortioxetine) patent listings